CN107043757B - Recombinant pichia pastoris for heterologous high-efficiency expression of rhizomucor miehei lipase and application thereof - Google Patents
Recombinant pichia pastoris for heterologous high-efficiency expression of rhizomucor miehei lipase and application thereof Download PDFInfo
- Publication number
- CN107043757B CN107043757B CN201710402790.XA CN201710402790A CN107043757B CN 107043757 B CN107043757 B CN 107043757B CN 201710402790 A CN201710402790 A CN 201710402790A CN 107043757 B CN107043757 B CN 107043757B
- Authority
- CN
- China
- Prior art keywords
- pichia pastoris
- pro
- rml
- expression
- sec31
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000235058 Komagataella pastoris Species 0.000 title claims abstract description 42
- 230000014509 gene expression Effects 0.000 title claims abstract description 22
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 title claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 54
- 230000028327 secretion Effects 0.000 claims abstract description 29
- 108090001060 Lipase Proteins 0.000 claims abstract description 25
- 101150092584 SEC31 gene Proteins 0.000 claims abstract description 25
- 102000004882 Lipase Human genes 0.000 claims abstract description 21
- 239000004367 Lipase Substances 0.000 claims abstract description 21
- 235000019421 lipase Nutrition 0.000 claims abstract description 21
- 230000002018 overexpression Effects 0.000 claims abstract description 14
- 239000013612 plasmid Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 241000235403 Rhizomucor miehei Species 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 10
- 239000013598 vector Substances 0.000 claims description 9
- 239000013613 expression plasmid Substances 0.000 claims description 8
- 238000010353 genetic engineering Methods 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 238000011529 RT qPCR Methods 0.000 claims description 4
- 230000003248 secreting effect Effects 0.000 claims description 4
- 239000000411 inducer Substances 0.000 claims description 2
- 230000006698 induction Effects 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 33
- 108090000790 Enzymes Proteins 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 28
- 230000001131 transforming effect Effects 0.000 abstract description 2
- 101100256382 Candida albicans (strain SC5314 / ATCC MYA-2876) PGA63 gene Proteins 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000012634 fragment Substances 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 101710194180 Alcohol oxidase 1 Proteins 0.000 description 3
- 102100036826 Aldehyde oxidase Human genes 0.000 description 3
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000001190 Q-PCR Methods 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000002288 golgi apparatus Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102100031375 Endothelial lipase Human genes 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003225 biodiesel Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- IWZKICVEHNUQTL-UHFFFAOYSA-M potassium hydrogen phthalate Chemical compound [K+].OC(=O)C1=CC=CC=C1C([O-])=O IWZKICVEHNUQTL-UHFFFAOYSA-M 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000028973 vesicle-mediated transport Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a recombinant pichia pastoris for heterologous high-efficiency expression of lipase and application thereof. The recombinant pichia pastoris is obtained by transforming a plasmid SEC31-pPIC3.5K of an overexpression SEC31 gene into a recombinant pichia pastoris X-33 containing 4 copies of Pro-RML gene and capable of expressing Pro-RML. The invention effectively promotes the expression of the Rhizomucor miehei lipase and improves the secretion efficiency of the lipase, when the Rhizomucor miehei lipase is fermented in a shake flask for 144 hours, the enzyme activity reaches 996U/mL, the extracellular enzyme activity secretion efficiency of the strain reaches 38U/OD600The secretion efficiency is higher than the extracellular enzyme activity secretion efficiency (26U/OD) of the Pichia pastoris recombinant strain with 2 copies of Rhizomucor miehei lipase related to the patent CN103361327A600)。
Description
Technical Field
The invention belongs to the technical field of biology, and relates to a recombinant pichia pastoris for heterologous high-efficiency expression of lipase and application thereof.
Background
Lipases (EC 3.1.1.3) are a class of enzymes that can hydrolyze triacylglycerols. A variety of chemical reactions can be catalyzed such as: hydrolysis, esterification, transesterification, ammonolysis, and the like. The reactions catalyzed by lipases have several advantages over chemical methods: the method has the advantages of mild reaction conditions, few byproducts, no pollution and the like, is widely applied to industries such as food, medicine, cosmetics, petroleum and the like, and is called as enzyme for the third industry.
At present, the production of lipase mainly adopts a strategy of heterologous protein expression. However, there are many factors affecting the expression of heterologous proteins, and they are mainly classified into two categories: external and internal causes. The external factors include: culture medium, culture conditions, and the like; the internal factors include the preference of gene codon, gene copy number, carrier performance, the bearing capacity of host protein synthesizing and secreting path, etc. Due to a plurality of limiting factors, the expression level of most enzymes still cannot meet the requirement of industrial production. How to improve the capability of a host to secrete heterologous lipase is a problem to be solved for industrial application of lipase.
The synthesis and secretion of heterologous proteins in host cells involve multiple steps, target genes are transcribed and translated into nascent peptides, the nascent peptides enter endoplasmic reticulum, enter Golgi apparatus through vesicles after folding modification in the endoplasmic reticulum, and are secreted out of cells through the vesicles after further folding modification in the Golgi apparatus. During expression of the heterologous protein, a step of vesicle trafficking is involved. Especially during overexpression of heterologous proteins, the number of vesicles may not be sufficient to allow the transport of so many nascent peptides. Thus, by overexpressing vesicle composition proteins in the host, such as SEC31, etc., it is possible to facilitate the timely transport of nascent peptides.
Rhizomucor miehei lipase is a1, 3 site specific lipase and can be used in various aspects of biodiesel preparation. The CN103361327A of the previous application of the applicant discloses a recombinant Pichia pastoris for heterologous efficient secretory expression of rhizomucor miehei lipase, which is obtained by introducing 2 copies of a coding rhizomucor miehei lipase gene (with self leader peptide) by adopting a molecular biology technology and constructing a vector capable of being expressed in Pichia pastoris. Although the recombinant pichia pastoris realizes the heterologous secretion of the rhizomucor miehei lipase, the enzyme activity of the secreted recombinase is higher, but the secretion quantity of the recombinant pichia pastoris is the soft rib which influences the popularization and application of the recombinant pichia pastoris all the time.
Disclosure of Invention
The first purpose of the invention is to provide a recombinant pichia pastoris strain of rhizomucor miehei lipase with high secretion efficiency.
The second object of the present invention is to provide a method for improving the secretion efficiency of the lipase.
The purpose of the invention can be realized by the following technical scheme:
the genetic engineering bacteria are obtained by converting a plasmid SEC31-pPIC3.5K of an overexpression SEC31 gene into a recombinant Pichia pastoris X-33 containing 4 copies of Pro-RML genes and capable of expressing Pro-RML.
The recombinant Pichia pastoris X-33 containing the Pro-RML gene with the copy number of 4 is obtained by inserting a lipase gene Pro-RML containing a leader peptide into a Pichia pastoris expression vector pPICZ α A to construct an expression vector pPICZ α A-2prorml containing the Pro-RML gene with the copy number of 2, and the plasmid construction process is shown in figure 2. the pPICZ α A-2prorml is transformed into the Pichia pastoris X-33 and screened by a qPCR method to obtain the recombinant Pichia pastoris X-33 containing the Pro-RML gene with the copy number of 4 and capable of expressing Pro-RML.
The invention clones 1, 3-position specific lipase (Pro-RML) gene Pro-RML containing leader peptide from Rhizomucor miehei strain, the nucleotide sequence is shown as SEQ ID No.1, the total length of the gene is (1017) bp, analysis shows that GC content is (48.9)%, and protein consisting of (339) amino acids is coded.
The invention finds that unfolded or misfolded protein is generated in a genetic engineering bacterium capable of expressing Pro-RML with 4 copies of genes and accumulated in an endoplasmic reticulum cavity, so that pressure is generated on the endoplasmic reticulum, and a vesicle-constituting protein gene SEC31 is connected to a pPIC3.5K vector (figure 5) and is transformed into m α -4pRML-X33, so that the genetic engineering strain m α -4pRML-X33S capable of expressing Pro-RML and over-expressing the 4 copies of Pro-RML genes of SEC31 is obtained.
The gene engineering bacteria of the invention are applied to heterologous secretion expression of Rhizomucor miehei lipase.
A method for efficiently carrying out heterologous secretion expression on Rhizomucor miehei lipase is characterized in that lipase Pro-RML is obtained by culturing the genetic engineering bacteria of 4 copy number Pro-RML gene of over-expression SEC31 and carrying out induced expression. The culture conditions were 28 ℃ and initial pH 7 at 200rpm for 144 hours. The induction condition is that inducer methanol is supplemented every 24 hours until the final concentration of methanol is 1.0% (v/v), the method is adopted, the flask is cultured for 144 hours, olive oil is taken as a substrate, and the enzyme activity is 996U/mL. The extracellular enzyme activity secretion efficiency of the strain is found to be obviously improved and reaches 38U/OD600Higher than 2 copies of the strain involved in the patent CN103361327A (the active secretion efficiency of the extracellular enzyme is 26U/OD)600)。
The beneficial technical effects are as follows:
the lipase is expressed in pichia pastoris, so that the lipase is superiorChanging the gene copy number of the strain to obtain a pichia pastoris recombinant strain containing 4 Mucor miehei lipase copy numbers, and fermenting for 144h with the extracellular enzyme activity of 704U/mL and the enzyme activity secretion efficiency of 29U/OD600. It was also found that a UPR reaction was generated inside the strain and that a large amount of unfolded or misfolded proteins accumulated in the lumen of the endoplasmic reticulum. The experiment effectively promotes the secretion of the Rhizomucor miehei lipase by over-expressing the vesicle composition protein SEC31 in the strain, improves the extracellular enzyme activity secretion efficiency of the lipase, ensures that the enzyme activity reaches 996U/mL and the enzyme activity secretion efficiency of the strain reaches 38U/OD during the shake flask fermentation for 144h600The secretion efficiency is higher than that of the Pichia pastoris recombinant strain with 2 copies of Rhizomucor miehei lipase related to the patent CN103361327A (the extracellular enzyme activity secretion efficiency is 26U/OD)600)。
Drawings
FIG. 1 shows the electrophoresis of the restriction and recovery of the target gene, lane 1 shows DNA standard molecular weights (kb) of 4.5,3.0,2.0,1.2,0.8 and 0.50.2; lane 2, the 1017bp fragment (indicated by the arrow) was recovered from the target gene by DNA digestion;
FIG. 22 is a flow chart of copy expression plasmid construction;
FIG. 32 is a diagram showing the double restriction electrophoresis of the copy expression plasmid, wherein lane 1 shows the results of double restriction of DNA standard molecular weight (kb):15,10,7.5,5,2.5,1,0.25, and lane 2: 2 shows the results of double restriction of expression plasmid pPICZ α + M α -2prorml with Bgl II and BamH I, and arrows indicate the expression frames.
FIG. 4 Standard Curve for copy number Strain determination
FIG. 5 construction procedure of over-expression SEC31 vector
FIG. 6 comparison of Shake flask fermentation results of strains overexpressing SEC31
A: the cell growth of each strain in the fermentation process; b: extracellular enzyme activity of each strain in the fermentation process; c: the enzyme activity secretion efficiency of each strain in the fermentation process;
the specific implementation mode is as follows:
the following examples further illustrate the present invention but are not to be construed as limiting the invention. Modifications or substitutions to methods, procedures, or conditions of the invention may be made without departing from the spirit and scope of the invention.
Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art.
The percent in the present invention means mass percent unless otherwise specified; but the percentage of the solution, unless otherwise specified, means that 100ml of the solution contains several grams of solute; the percentage between the liquids refers to the ratio of the volumes at 20 ℃. The steps of conventional experimental operations such as enzyme digestion, ligation, recovery, transformation, PCR amplification and the like are described in molecular cloning (third edition). Primer synthesis and sequencing was done by english jun (Invitrogen) bio-inc.
EXAMPLE 1 preparation of Mucor miehei cDNA
1.1 extraction of Total RNA from Mucor miehei
(1) Taking appropriate amount of Rhizomucor miehei mycelium, drying with filter paper, grinding with liquid nitrogen, adding 1ml Trizol reagent (Invitrogen), shaking with oscillator for 5min, and standing at room temperature for 1 min;
(2) adding 0.2ml chloroform, shaking for 15s, and standing for 2 min;
(3)4℃,12000rpm,15min;
(4) sucking supernatant, adding equal volume of isopropanol, and precipitating at-20 deg.C for 30 min;
(5)4℃,12000rpm,15min;
(6) the supernatant was decanted off and the precipitate was washed with 1ml of 75% ethanol at 7500rpm, 4 ℃ for 5 min;
(7) repeating the step (6) once;
(8) pouring off the supernatant, and drying for 10 min;
(9) adding a proper amount of DEPC water to dissolve to obtain total RNA;
1.2 preparation of the first Strand of the cDNA of Mucor miehei
The reverse transcription was specifically performed using reverse transcriptase (MMLV) manufactured by Promega corporation as follows:
a25. mu.l reaction was prepared by adding the following ingredients to a nuclease-free centrifuge tube:
heating at 95 deg.C for 5min to terminate reaction, and freezing for storage.
EXAMPLE 22 construction of the copy of pPICZ α A-2prorml plasmid
2.1 primer design
Based on the sequence of the rml gene in GenBank (GenBank accession No. A02536.1), the following pair of primers were designed and synthesized:
FW(P1):5’—CGGAATTCGTGCCAATCAAGAG—3’(SEQ ID NO.2)
REV(P2):5’—TAGTCTAGAGTACAGAGGCCTGTG—3’(SEQ ID NO.3)
the two ends of P1 and P2 are respectively designed with EcoR I and Not I restriction enzyme sites (see the italic underlined part in the sequence)
2.2 PCR amplification of Rhizomucor miehei Lipase pro-rml containing leader peptide
The PCR reaction system is characterized in that a P1 primer and a P2 primer are adopted, and Mucor miehei (Boel E, Huge-Jensen B, Christensen M, Thim L, Fiil N: Rhizomucor miehei trigyceride is synthesized as appropriate for Lipidss 1988,23(7):701 and 706.) (stored in a room) cDNA is taken as a template:
the reaction conditions are as follows: circulating 30 times at 95 deg.C for 5min, 5 deg.C for 40s, 60 deg.C for 40s, and 72 deg.C for 1min, at 72 deg.C for 10min, and at 4 deg.C for 2 min.
2.3 recovery of the fragment of interest from the PCR reaction product
The target gene fragment is purified and recovered from the PCR product by a gel cutting and column passing method, the PCR reaction product is subjected to agarose gel electrophoresis, the target gene DNA is cut under the irradiation of an ultraviolet lamp, the length of the target gene is 1017bp (figure 1), and the target gene is recovered according to the method of a DNA recovery kit instruction (purchased from Tiangen company, product number is DP 209-02).
2.4 cloning of TA
The PCR-recovered product was ligated to the vector pMD18-T-Simple (purchased from TaKaRa Co.), and the ligation was performed according to the kit (Code No. D104A) provided by TaKaRa Co.
2.5 the gene of interest was ligated into the Pichia pastoris expression vector pPICZ α A.
2.5.12 copy expression plasmid construction
The method comprises the steps of carrying out double digestion on pMD18-T-prorml and pPICZ α A by using restriction enzymes EcoR I and Not I respectively, then recovering target fragments, connecting the target fragments by using T4 ligase, transforming a connecting product into escherichia coli DH5 α (purchased from Shanghai Biotechnology Limited), obtaining a single-copy expression plasmid pPICZ α A-prorml, carrying out double digestion on BamH I and BglII on the single-copy pPICZ α A-prorml to obtain an expression frame containing a pro-rml fragment, carrying out BamH I single digestion on the pZ α A-prorml to obtain a PICpZ α A vector fragment containing a single-copy pro-rml, connecting the expression frame and the vector fragment to obtain a 2-copy pZ α A-2prorml vector, transferring the PICZ α A-2 rml into escherichia coli DH5 α for amplification and PCR detection, and sending a sequence detection scheme 3 to a person with a picture of the drawing.
EXAMPLE 34 Pichia recombinant Strain Screen with copies of the pro-rml Gene
3.1 preparation of Pichia pastoris X-33 (purchased from Invitrogen) electrotransformation competent cells and electroporation thereof
(1) Picking fresh single colony in 5ml YPD liquid culture medium, culturing at 30 deg.c and 250rpm for 12-14 hr;
(2) inoculating into 2L Erlenmeyer flask containing 500ml YPD medium at 0.1%, culturing at 30 deg.C and 250rpm for 12-14 hr to make OD600=1.3-1.5;
(3) Centrifuging at 1500rpm at 4 deg.C for 5min, and collecting cells;
(4) cells were washed twice with 500-;
(5) the cells were washed once with 20ml of ice-pre-chilled 1M sorbitol solution;
(6) resuspending the cells with 1ml of ice-precooled 1M sorbitol solution to a final volume of about 1.5ml, and packaging in 80. mu.l small centrifuge tubes;
3.2 electroporation transformation of Pichia pastoris cells
(1) About 10. mu.l of the prepared non-linearized 2-copy expression plasmid of about 100. mu.g/. mu.l is mixed with 80. mu.l of yeast competent cells, and the mixture is left on ice for about 5 minutes;
(2) transferring the DNA-mixed competent cells into an ice-precooled 0.2cm electric rotor;
converting at a voltage of 1.5 kilovolts;
(3) then 1ml of ice-pre-cooled 1M sorbitol solution was immediately added to the transformed cells, the cells were mixed well and transferred to a 1.5ml small centrifuge tube and allowed to stand at 30 ℃ for 1-2 h.
(4) 50-200ul of the suspension was spread on YPDS plates (yeast extract 1%, peptone 2%, dextrase 2%, Sorbitol 1M, agar 2%,) containing 100ug/ml, and cultured at 30 ℃ for 2 to 3 days to observe the results.
3.3. Screening of recombinant strains containing 4 copies of the pro-rml Gene
3.3.1 identification of correctly integrated transformants by colony PCR
Positive colonies were selected on the plates and further verified to give correctly integrated transformants by the yeast colony PCR method using 5 'AOX 1, 3' AOX1 as primers.
The primer sequence is as follows: 5' AOX 1: 5'-GACTGGTTCCAATTGACAAGC-3' (SEQ ID NO.4)
3' AOX 1: 5'-GCAAATGGCATTCTGACATCC-3' (SEQ ID NO.5) template processing method:
(1) a small amount of colonies were picked up with a sterile pipette tip and dissolved in 50. mu.l of D2-Buffer (1L: guanidinium isothiocyanate 472.64g,1 mol/L50 ml of pH8.0Tris-HCl Buffer, β -mercaptoethanol 7ml) and mixed well;
(2) placing the mixed solution in 100 deg.C boiling water bath for 5 min;
(3) centrifuging at 12000rpm for 30s, and discarding the supernatant;
(4) washing the precipitate with sterile water for 2 times;
(5) the precipitate was dissolved in 20. mu.l of ddH2O, acting at 95 ℃ for 5 min;
(6) and centrifuging to obtain supernatant as the template.
And (3) PCR reaction system:
reaction conditions are as follows: 5min at 95 ℃; 30cycles at 95 ℃ for 40s, 60 ℃ for 40s, 72 ℃ for 1min for 30 s; 10min at 72 ℃.
3.3.2 determination of 4 copies of the Strain by qPCR
Extracting the genome of the screened pichia pastoris recombinant by using a TIANGEN Yeast genome DNA extraction Kit (TIANAmp Yeast DNA Kit, cat number: DP307-02), selecting glyceraldehyde-3-phosphate dehydrogenase gene (gap) as an internal reference gene by using the genome of the recombinant containing only one copy of pro-rml as a template, diluting the template at different concentrations, detecting by Q-PCR (Q-PCR), respectively obtaining a standard curve (figure 4) between the log value and the Ct value of the template amount of the target gene pro-rml and the internal reference gene gap, wherein the standard curve is shown in a qPCR data of a positive strain in a table 1, substituting the Ct (pro-rml) and the Ct (gap) of the internal reference gene of an unknown sample into a formula to obtain template amounts of the target gene and the internal reference gene, namely pro-rml (copy quality) and gap (copy quality), and calculating a strain 85m-33 ML 83-33 according to the following copy number formula:
the results are shown in Table 1:
TABLE 1 determination of copy number of recombinant strains
Example 4 overexpression of the SEC31 Gene in 4 copies of the above-described bacteria
4.1 acquisition of SEC31 Gene fragment
With PSEC31-F(CGGGATCCACCATGGTGGTACCCCTAAGTCAGTT (SEQ ID NO.6)) and PSEC31-R(ATAAGAATGCGGCCGCCTAGTTGATGATGTAATTCAGACTGC (SEQ ID NO.7)) as a primer, the genome of Pichia pastoris X-33 as a template (extracted by a TIANGEN Yeast genomic DNA Kit (Cat: DP 307-02)), and a fragment of SEC31 gene was obtained by the following PCR system and amplification conditions。
And (3) PCR reaction system:
reaction conditions are as follows: 5min at 95 ℃; 30cycles at 95 ℃ for 40s, 60 ℃ for 40s and 72 ℃ for 2 min; 10min at 72 ℃.
4.2 construction of the overexpression plasmid SEC31-pPIC3.5K
The PCR recovery product of SEC31 gene is connected to carrier pMD18-T-Simple (purchased from TaKaRa company), the connection reaction is operated according to the instruction of kit (Code No. D104A) provided by TaKaRa company, the correct SEC31-pMD18T plasmid is obtained by sequencing, the SEC31 fragment and pPIC3.5K are recovered by cutting glue respectively by using restriction endonucleases BamH I and Not I, the ligation product is connected by using T4 ligase, the ligation product is transformed into Escherichia coli DH5 α, and the over-expression plasmid SEC31-pPIC3.5K is obtained by plasmid extraction, PCR, BamHI and Not I double digestion verification screening, and the construction process is shown in figure 5.
4.3 overexpression vector SEC31-pPIC3.5K is electrically transformed into pichia pastoris containing 4 copies of lipase gene and screening of positive strains.
The SEC31-pPIC3.5K extraction, linearization and electrotransformation method is the same as 3.2, the screening process of the positive strain is the same as 3.3, the primers used for screening are D-SEC31-F (CGTGTTCCTCAATCAGCCA (SEQ ID NO.8)) and D-SEC31-R (GCAAATGGCATTCTGACATCC (SEQ ID NO. 9)). the PCR reaction system and the amplification conditions are the same as 3.3, and the strain m α -4pRML-X33S of over-expression SEC31 is obtained.
4.4 expression of the Lipase of interest in Pichia pastoris
Determination of lipase activity by NaOH titration
(1) Preparation of 0.05M NaOH: first use without CO2Preparing 5M NaOH stock solution by using water; accurately diluting by 50 times, weighing 0.38g of potassium hydrogen phthalate, drying at 100 deg.C to constant weight, and dissolving in 80ml of solution without CO2In water, the accurate concentration is calibrated and then estimatedCalculating the concentration of the stock solution; 0.05M NaOH solution to free of CO2Preparing water in situ after using a stock solution;
(2) preparing a PVA-olive oil emulsion substrate: mixing 100ml of olive oil and 300ml of 2% PVA1750 (polyvinyl alcohol), heating for dissolving, emulsifying by ultrasonic waves with the power of 300W, the ultrasonic waves for 3s, the intermittence for 4s, the circulation for 99 times and the like;
(3) adding 5ml of emulsion substrate and 4ml of 0.1M disodium hydrogen phosphate-citric acid buffer solution with pH of 6.0 into a 150ml triangular flask, placing in a constant temperature water bath shaker at 35 ℃, and incubating for 5min at 150 rpm;
(4) adding 1ml of properly diluted enzyme solution into the substrate and the buffer solution, reacting at 35 ℃ and 150rpm for 10min, and adding 15ml of absolute ethyl alcohol to terminate the reaction;
(5) dripping 4 drops of phenolphthalein as an indicator, and titrating the fatty acid generated by enzymolysis by using 0.05M NaOH until the reaction solution turns pink;
the blank operation is identical to that described above except that the fermentation broth is mixed with absolute ethanol for 10min and added to the substrate and buffer.
The enzyme activity is defined as the amount of enzyme that releases 1. mu. mol of fatty acid in 1min under the measurement conditions as one unit of enzyme activity.
Single colonies of 4 copies of pro-rml gene strain overexpressing SEC31 (m α -4pRML-X33S), 4 copies of pro-rml gene strain not overexpressing SEC31 (m α -4pRML-X33) and 2 copies of pro-rml gene strain involved in patent CN103361327A (m α -2pRML-X33) were picked, inoculated in 25ml of BMGY medium (1% yeast powder, 2% peptone, 1% glycerol), and shake-cultured at OD 28 ℃ and 200rpm until the OD reaches 28 ℃600About 4.0-8.0, transferring into 500ml triangular flask containing 50ml BMMY culture medium (1% yeast powder, 2% peptone, 1.0% methanol, 100mmol/l phosphate buffer solution, pH 7.0), continuing culturing under the same culture condition, supplementing 100% methanol to the culture medium every 24 hours until the final concentration is 1.0% (v/v), and inducing and expressing for 6 days. Sampling at regular intervals, and measuring the cell density (OD)600) And the enzyme activity of the extracellular Rhizomucor miehei lipase, and calculating the secretion efficiency of the extracellular enzyme activity, wherein the detection result is shown in figure 6.
From the cell growth of each strain (FIG. 6A), the flask was fermented for 144h, m α -2pRML-X33 (OD)60039) was superior to m α -4pRML-X33S (OD)60025.9) and m α -4pRML-X33 (OD)60024.25). The growth condition of the recombinant Pichia pastoris cell over-expressing the 4 copies of the pro-rml gene of SEC31 is slightly lower than that of the recombinant Pichia pastoris cell with 2 copies of the pro-rml gene, but the cell growth condition is not changed greatly compared with that of the recombinant Pichia pastoris cell with 4 copies of the pro-rml gene.
The extracellular enzyme activity secretion of each strain is shown in figure 6B, when the fermentation time is 144h, the enzyme activities of m α -4pRML-X33S and m α -2pRML-X33 are similar, the highest enzyme activities are 996U/ml and 1023U/ml respectively, and are both higher than 704U/ml of m α -4pRML-X33, compared with the recombinant Pichia pastoris of 4 copies of pro-rml gene without over-expressing SEC31, the over-expression SEC31 can promote the secretion of Mucor miehei lipase.
The secretion efficiency of the recombinant strain is calculated according to the enzyme activity and the cell growth condition, and the result is shown in figure 6 C.m α -4pRML-X33S, the secretion efficiency of the extracellular enzyme activity is higher than that of m α -2pRML-X33 and m α -4pRML-X33, and when the recombinant strain is fermented for 144h, the secretion efficiency of the extracellular enzyme activity of m α -4pRML-X33H, m α -2pRML-X33 and m α -4pRML-X33 are respectively 38U/OD600、26U/OD600And 29U/OD600. The results show that overexpression of SEC31 improves the extracellular enzyme activity secretion efficiency of recombinant Pichia pastoris with 4 copies of pro-rml gene.
With the results of FIG. 6 taken together, the extracellular enzyme activity of the Pichia pastoris recombinant containing 4 copies of pro-rml gene overexpressing SEC31 reached the maximum of 996U/ml and the extracellular enzyme activity secretion efficiency reached 38U/OD under the condition of shake flask culture of BMMY medium (initial pH 7, culture temperature 28 ℃) for 144 hours600Higher than 26U/OD of 2 copies strain related to patent CN103361327A600。
<110> university of Jiangsu profession
<120> recombinant pichia pastoris for heterologous high-efficiency expression of lipase and application thereof
<160>9
<210>1
<211>1017
<212>
<213> Mucor miehei Rice (Rhizomucor miehei)
<220>
<223> pro-rml Gene
<400>1
gtgccaatca agagacaatc aaacagcacg gtggatagtc tgccacccct catcccctct 60
cgaacctcgg caccttcatc atcaccaagc acaaccgacc ctgaagctcc agccatgagt 120
cgcaatggac cgctgccctc ggatgtagag actaaatatg gcatggcttt gaatgctact 180
tcctatccgg attctgtggt ccaagcaatg agcattgatg gtggtatccg cgctgcgacc 240
tcgcaagaaa tcaatgaatt gacttattac actacactat ctgccaactc gtactgccgc 300
actgtcattc ctggagctac ctgggactgt atccactgtg atgcaacgga ggatctcaag 360
attatcaaga cttggagcac gctcatctat gatacaaatg caatggttgc acgtggtgac 420
agcgaaaaaa ctatctatat cgttttccga ggttcgagct ctatccgcaa ctggattgct 480
gatctcacct ttgtgccagt ttcatatcct ccggtcagtg gtacaaaagt acacaaggga 540
ttcctggaca gttacgggga agttcaaaac gagcttgttg ctactgttct tgatcaattc 600
aagcaatatc caagctacaa ggttgctgtt acaggtcact cactcggtgg tgctactgcg 660
ttgctttgcg ccctgggtct ctatcaacga gaagaaggac tctcatccag caacttgttc 720
ctttacactc aaggtcaacc acgggtaggc gaccctgcct ttgccaacta cgttgttagc 780
accggcattc cttacaggcg cacggtcaat gaacgagata tcgttcctca tcttccacct 840
gctgcttttg gttttctcca cgctggcgag gagtattgga ttactgacaa tagcccagag 900
actgttcagg tctgcacaag cgatctggaa acctctgatt gctctaacag cattgttccc 960
ttcacaagtg ttcttgacca tctctcgtac tttggtatca acacaggcct ctgtact 1017
<210>2
<211>22
<212>DNA
<213> Artificial sequence
<220>
<223> primer P1
<400>2
cggaattcgt gccaatcaag ag 22
<210>3
<211>24
<212>DNA
<213> Artificial sequence
<220>
<223> primer P2
<400>3
tagtctagag tacagaggcc tgtg 24
<210>4
<211>21
<212>DNA
<213> Artificial sequence
<220>
<223> primer 5' AOX1
<400>4
gactggttcc aattgacaag c 21
<210>5
<211>21
<212>DNA
<213> Artificial sequence
<220>
<223> primer 3' AOX1
<400>5
gcaaatggca ttctgacatc c 21
<210>6
<211>34
<212>DNA
<213> Artificial sequence
<220>
<223> primer PSEC31-F
<400>6
cgggatccac catggtggta cccctaagtc agtt 34
<210>7
<211>34
<212>DNA
<213> Artificial sequence
<220>
<223> primer PSEC31-R
<400>7
ataagaatgc ggccgcctag ttgatgatgt aattcagact gc 42
<210>8
<211>19
<212>DNA
<213> Artificial sequence
<220>
<223> primer D-SEC31-F
<400>8
cgtgttcctc aatcagcca 19
<210>9
<211>21
<212>DNA
<213> Artificial sequence
<220>
<223> primer D-SEC31-R
<400>9
gcaaatggca ttctgacatc c 21
<210>10
<211>1116
<212>DNA
<213> Pichia pastoris X-33
<220>
<223> SEC31 Gene
<400>10
atggtggtac ccctaagtca gttcccttcg ccgcccaact caagtggcga cggctgcgag 60
aactcaagta cagtcttttc caaggactgt gtcaagagga ctgcatcgcc attagaccct 120
caatctcaat ttagagtctc cccaaactcg tacactacat ccacaaacta ttctaccccg 180
gtttcttccc acgaaacttt gtcctcctca acatccggga tctcagtgac aggcgttctg 240
ctaccatcaa tagattcatt agcacgctca atctcctata caggacgaga cgctgttcct 300
ttcaacttgt ccacttggac tgacaagtca acacctgtta ctaattcttt tgtcatctct 360
cagtatgaag acacgcgtgt tcctcaatca gccaccagtt ctacacatcc aaacatacct 420
aaacacgcca aagagtatcc gttagcaaat gggccacctg ggtggtgttg gaattcccat 480
tccagtatgt cgacagacca accaatatat ccaggacacc aatatccacc accgcttcag 540
cagcactacc actttgcttc acccaggcaa ctatcaaact ctagctctgg gacgtcatcc 600
gttcctttcc aaccaccccc tgctggtcaa ttacaaccac aaggtaattc tatgttcata 660
cacatgccat tttcgctaaa tggcccacca gctgctggac agcaattgat accaccccaa 720
ggactagcct caatacctgt cggccccggc aacaacagtt ccctattggt tagccaaggt 780
gcacctggcg gctattcttt agcttcacca gcgttgtcac cggtagatgc gaccttcgaa 840
gatcccgtca agagactgcc caaaaagcgg acaaaaactg gatgtctcac ttgccgtaag 900
agacgaatca aatgtgacga acgcaagccg ttctgtttca actgtgaaaa aagcaaaaag 960
gtgtgtactg gttttacgca tctattcaaa gatcccccta gcaaatccta ccctcccagt 1020
tcagatggtg cctcccctgt tgccaatgac caccctgtcc ccccaaggca aaactttggt 1080
gaattgaggg gcagtctgaa ttacatcatc aactag 1116
Claims (6)
1. A genetic engineering bacterium for efficient heterologous secretion expression of Mucor miehei lipase is characterized in that the genetic engineering bacterium is obtained by converting a plasmid SEC31-pPIC3.5K of an over-expression SEC31 gene into a recombinant Pichia pastoris X-33 containing 4 copy numbers of Pro-RML genes and capable of expressing Pro-RML, the recombinant Pichia pastoris X-33 containing 4 copy numbers of Pro-RML genes is constructed by inserting the lipase gene Pro-RML containing a leader peptide into a Pichia pastoris expression vector pPICZ α A to obtain an expression vector pPICZ α A-2prorml containing 2 copy numbers of Pro-RML genes, the PICpZ α A-2prorml is converted into the Pichia pastoris X-33 and the recombinant Pichia pastoris X-33 containing 4 copy numbers of Pro-RML genes and capable of expressing Pro-RML is obtained by means of qPCR screening, wherein the nucleotide sequence of the recombinant Pichia pastoris X-33 is shown in SEQ ID No. 1.
2. The genetically engineered bacterium of claim 1, wherein the over-expression plasmid SEC31-pPIC3.5K is obtained by inserting SEC31 gene between BamH I and Not I cleavage sites of pPIC3.5K vector.
3. Use of the genetically engineered bacterium of any one of claims 1-2 for heterologous secretory expression of Rhizomucor miehei lipase.
4. A method for high-efficiency heterologous secretory expression of Rhizomucor miehei lipase is characterized in that lipase Pro-RML is obtained by culturing the genetic engineering bacteria of any one of claims 1-2 and performing induced expression.
5. The method according to claim 4, wherein the culturing is carried out under conditions of 28 ℃ and an initial pH of 7 at 200rpm for 144 hours.
6. The method according to claim 4, characterized in that the induction conditions are such that the inducer methanol is fed every 24 hours to a final methanol concentration of 1.0% (v/v).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710402790.XA CN107043757B (en) | 2017-06-01 | 2017-06-01 | Recombinant pichia pastoris for heterologous high-efficiency expression of rhizomucor miehei lipase and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710402790.XA CN107043757B (en) | 2017-06-01 | 2017-06-01 | Recombinant pichia pastoris for heterologous high-efficiency expression of rhizomucor miehei lipase and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107043757A CN107043757A (en) | 2017-08-15 |
CN107043757B true CN107043757B (en) | 2020-07-07 |
Family
ID=59546231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710402790.XA Expired - Fee Related CN107043757B (en) | 2017-06-01 | 2017-06-01 | Recombinant pichia pastoris for heterologous high-efficiency expression of rhizomucor miehei lipase and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107043757B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110923216B (en) * | 2018-09-19 | 2021-08-06 | 江苏师范大学 | Method for producing rhizomucor miehei lipase pRML enzyme powder |
CN110923260B (en) * | 2018-09-19 | 2022-06-03 | 江苏师范大学 | Engineering strain for producing rhizomucor miehei lipase powder and application thereof |
CN111763665B (en) * | 2019-04-01 | 2022-08-12 | 江苏师范大学 | Preparation method of high-activity sweet potato chitinase and application of high-activity sweet potato chitinase in preparation of plant pathogenic fungus antibacterial agent |
CN114574617B (en) * | 2022-03-08 | 2022-12-27 | 江南大学 | Reference gene of pichia pastoris under different carbon sources, and primer and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008128701A3 (en) * | 2007-04-20 | 2009-03-12 | Polymun Scient Immunbio Forsch | Yeast expression systems |
CN103361327A (en) * | 2013-07-19 | 2013-10-23 | 中国农业大学 | Recombinant pichia pastoris for heterogenous high level expression of lipase |
CN103981197A (en) * | 2014-04-21 | 2014-08-13 | 中国科学院广州能源研究所 | Novel leader peptide-containing rhizomucor mieheilipase gene and expression of rhizomucor mieheilipase gene in pichia pastoris |
-
2017
- 2017-06-01 CN CN201710402790.XA patent/CN107043757B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008128701A3 (en) * | 2007-04-20 | 2009-03-12 | Polymun Scient Immunbio Forsch | Yeast expression systems |
CN103361327A (en) * | 2013-07-19 | 2013-10-23 | 中国农业大学 | Recombinant pichia pastoris for heterogenous high level expression of lipase |
CN103981197A (en) * | 2014-04-21 | 2014-08-13 | 中国科学院广州能源研究所 | Novel leader peptide-containing rhizomucor mieheilipase gene and expression of rhizomucor mieheilipase gene in pichia pastoris |
Also Published As
Publication number | Publication date |
---|---|
CN107043757A (en) | 2017-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107083373B (en) | Recombinant pichia pastoris for heterologous high-efficiency expression of lipase and application thereof | |
CN107043757B (en) | Recombinant pichia pastoris for heterologous high-efficiency expression of rhizomucor miehei lipase and application thereof | |
CN104152484B (en) | A kind of method for improving Pichia pastoris secreting type exogenous protein expression amount | |
CN103361327A (en) | Recombinant pichia pastoris for heterogenous high level expression of lipase | |
CN107012130A (en) | A kind of glucose oxidase mutant and its encoding gene and application | |
CN116286900B (en) | Acetic acid permease A gene RkAcpa and application thereof | |
CN110066323B (en) | Microalgae light-harvesting protein NoHLR1 gene and application thereof | |
CN104232611A (en) | Recombinant beauveria brongniartii proteinase K as well as industrial production and purification method thereof | |
Chen et al. | Heterologous expression and characterization of Penicillium citrinum nuclease P1 in Aspergillus niger and its application in the production of nucleotides | |
CN111500479B (en) | Construction and application of non-methanol-induced dual-promoter pichia pastoris engineering bacteria | |
CN107778365B (en) | Multi-point integrated recombinant protein expression method | |
CN110923216B (en) | Method for producing rhizomucor miehei lipase pRML enzyme powder | |
CN116064266B (en) | Recombinant saccharomyces cerevisiae with enhanced salt stress resistance, and construction method and application thereof | |
US20210309982A1 (en) | Materials and methods for creating strains of saccharomyces cerevisiae that exhibit an increased ability to ferment oligosaccharides into ethanol | |
CN108949602B (en) | High-yield xylanase saccharomyces cerevisiae and application thereof | |
CN107236680B (en) | Pichia pastoris recombinant bacterium for expressing Streptomyces sp.FA1-derived xylanase | |
CN113801801B (en) | Recombinant strain for efficiently producing alkaline pectinase and application thereof | |
CN110923260B (en) | Engineering strain for producing rhizomucor miehei lipase powder and application thereof | |
CN110551702B (en) | Recombinant aspergillus tubingensis tannase and expression and application thereof | |
CN112852655A (en) | Saccharomyces cerevisiae engineering bacterium for displaying acid protease on cell surface as well as construction method and application thereof | |
CN100336906C (en) | Lipase gene sequence and its application in yeast | |
CN1485431A (en) | Gene engineering yeast strain of expressing beta-1,3-1,4-glucanase | |
CN116121092B (en) | Recombinant saccharomyces cerevisiae with enhanced multiple stress resistance, construction method and application thereof | |
CN110923215B (en) | Method for producing rhizomucor miehei lipase mRML enzyme powder | |
CN110628804A (en) | Method for constructing saccharomyces cerevisiae strain with high tolerance to isobutanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200707 |